Skip to main content
. 2024 Nov 16;31(11):7244–7257. doi: 10.3390/curroncol31110534

Figure 4.

Figure 4

Bar chart describing provider-reported barriers to use of biomarker-associated targeted therapy. The “Other” bar includes the following responses: inadequate specimen size (N = 1), limited experience with administering targeted therapy (N = 1).